Article

VEL products reinstated

Vision-Ease Lens (VEL) has reinstated the availability of nearly all of its product styles, 17 months after a fire at the company?s manufacturing facility in Jakarta, Indonesia, led to a temporary suspension of some styles. No employees were injured in the November, 2009 fire, but production was halted at the facility while it was rebuilt.

Ramsey, MN-Vision-Ease Lens (VEL) has reinstated the availability of nearly all of its product styles 17 months after a fire at the company’s manufacturing facility in Jakarta, Indonesia, led to a temporary suspension of some lens styles. No employees were injured in the November 2009 fire, but production was halted at the facility while it was rebuilt.

Earlier this year, VEL restarted production on the balance of its core polycarbonate lens line, and is now stocking and shipping Continua SFSV 71, 75, and 80 mm and Continua FSV 65, 75 mm lenses. Other previously reinstated products since the fire include: Continua Tintable FSV (Aspheric 65 mm, Spherical 75 mm), Tegra FSV (Aspheric 65 mm and 75 mm), Continua multifocals (D28, D35, 7x28, and 8x35), and all glass products.

VEL said its Continua FSVAR (Aspheric 65 mm, Spherical 75 mm) lenses have been discontinued and will be replaced with a new, upgraded version with Super-Hydro AR coating, set to launch in June 2011.

According to VEL, the rebuilt plant houses state-of-the-art manufacturing equipment, and meets international standards for natural disasters, including earthquakes and tsunamis, and houses the latest fire-suppressant technologies available.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.